Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.
Zhang J, Nannapaneni S, Wang D, Liu F, Wang X, Jin R, Liu X, Rahman MA, Peng X, Qian G, Chen ZG, Wong KK, Khuri FR, Zhou W, Shin DM.
Zhang J, et al. Among authors: liu x, liu f.
Oncotarget. 2017 Aug 1;8(35):59008-59022. doi: 10.18632/oncotarget.19779. eCollection 2017 Aug 29.
Oncotarget. 2017.
PMID: 28938614
Free PMC article.